A phase II/III study of high-dose, intermittent sunitinib in patients with recurrent glioblastoma multiforme: the STELLAR Study
Not yet recruiting
Phase of Trial: Phase II/III
Latest Information Update: 05 Aug 2017
At a glance
- Drugs Sunitinib (Primary) ; Lomustine
- Indications Glioblastoma
- Focus Therapeutic Use
- Acronyms STELLAR
- 31 Jul 2017 Planned initiation date changed from 1 Jun 2017 to 1 Aug 2017.
- 03 May 2017 Planned initiation date changed from 1 Mar 2017 to 1 Jun 2017.
- 30 Nov 2016 New trial record